On today's episode, Manaswini discusses the Covaxin crisis. As children aged between 15 and 18 become eligible for Covid-19 vaccinations, there is a lot of confusion. Why? The lack of transparency behind Bharat Biotech's Covaxin's expiry date extensions. In other news, she highlights Tesla's achievements over the last year. Musk appears to have a lot to look forward to in the year 2022.
See omnystudio.com/listener for privacy information.
